Pharmaceuticals in India

Pharmaceuticals in India


  • Products Id :- OHMF4236
  • |
  • Pages: 40
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Pharmaceuticals in India

Summary

Pharmaceuticals in India industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the India pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The Indian pharmaceuticals market had total revenues of USD 35.2bn in 2017, representing a compound annual growth rate (CAGR) of 15.9% between 2013 and 2017.

- One unique characteristic of the market is that the priorities of consumers in developing countries can be focused in different areas than expected, and this entirely changes how companies have to do business.

- Bourgeoning middle class households, coupled with improvements in medical infrastructure and the increased penetration of health insurance in the country has driven growth in the India pharmaceuticals market.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in India

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in India

- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the India pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the India pharmaceuticals market by value in 2017?

- What will be the size of the India pharmaceuticals market in 2022?

- What factors are affecting the strength of competition in the India pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitiors in India's pharmaceuticals market?



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Geography segmentation 2

Market share 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Geography segmentation 10

Market share 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 15

Supplier power 17

New entrants 18

Threat of substitutes 20

Degree of rivalry 21

Leading Companies 23

Aurobindo Pharma Limited 23

Dr. Reddy's Laboratories Limited 26

Lupin Limited 29

Sun Pharmaceutical Industries Limited 32

Macroeconomic Indicators 35

Country data 35

Methodology 37

Industry associations 38

Related MarketLine research 38

Appendix 39

About MarketLine 39

List of Figures

Figure 1: India pharmaceuticals market value: USD billion, 2013-17

Figure 2: India pharmaceuticals market geography segmentation: % share, by value, 2017

Figure 3: India pharmaceuticals market share: % share, by value, 2017

Figure 4: India pharmaceuticals market value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the pharmaceuticals market in India, 2017

Figure 6: Drivers of buyer power in the pharmaceuticals market in India, 2017

Figure 7: Drivers of supplier power in the pharmaceuticals market in India, 2017

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2017

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2017

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in India, 2017

Figure 11: Aurobindo Pharma Limited: revenues & profitability

Figure 12: Aurobindo Pharma Limited: assets & liabilities

Figure 13: Dr. Reddy's Laboratories Limited: revenues & profitability

Figure 14: Dr. Reddy's Laboratories Limited: assets & liabilities

Figure 15: Lupin Limited: revenues & profitability

Figure 16: Lupin Limited: assets & liabilities

Figure 17: Sun Pharmaceutical Industries Limited: revenues & profitability

Figure 18: Sun Pharmaceutical Industries Limited: assets & liabilities

List of Tables

Table 1: India pharmaceuticals market value: USD billion, 2013-17

Table 2: India pharmaceuticals market geography segmentation: USD billion, 2017

Table 3: India pharmaceuticals market share: % share, by value, 2017

Table 4: India pharmaceuticals market value forecast: USD billion, 2017-22

Table 5: Aurobindo Pharma Limited: key facts

Table 6: Aurobindo Pharma Limited: key financials (USD )

Table 7: Aurobindo Pharma Limited: key financials (AUSD )

Table 8: Aurobindo Pharma Limited: key financial ratios

Table 9: Dr. Reddy's Laboratories Limited: key facts

Table 10: Dr. Reddy's Laboratories Limited: key financials (USD )

Table 11: Dr. Reddy's Laboratories Limited: key financials (Rs.)

Table 12: Dr. Reddy's Laboratories Limited: key financial ratios

Table 13: Lupin Limited: key facts

Table 14: Lupin Limited: key financials (USD )

Table 15: Lupin Limited: key financials (Rs.)

Table 16: Lupin Limited: key financial ratios

Table 17: Sun Pharmaceutical Industries Limited: key facts

Table 18: Sun Pharmaceutical Industries Limited: key financials (USD )

Table 19: Sun Pharmaceutical Industries Limited: key financials (Rs.)

Table 20: Sun Pharmaceutical Industries Limited: key financial ratios

Table 21: India size of population (million), 2013-17

Table 22: India gdp (constant 2005 prices, USD billion), 2013-17

Table 23: India gdp (current prices, USD billion), 2013-17

Table 24: India inflation, 2013-17

Table 25: India consumer price index (absolute), 2013-17

Table 26: India exchange rate, 2013-17

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license
Single User License
USD 350 INR 25515
Site License
USD 700 INR 51030
Corporate User License
USD 1050 INR 76545

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com